EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Humacyte, Inc. (HUMA) had EBIT Margin of -5306.03% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.04M |
|
$-40.83M |
|
$9.70M |
|
$-7.66M |
|
$110.17M |
|
$-108.14M |
|
$67.30M |
|
$-40.83M |
|
$-40.83M |
|
$-40.83M |
|
$-40.83M |
|
$-40.83M |
|
$-40.83M |
|
$-108.14M |
|
$-100.79M |
|
158.16M |
|
158.16M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$67.80M |
|
$18.54M |
|
$48.57M |
|
$116.37M |
|
$18.37M |
|
$62.42M |
|
$94.89M |
|
$113.26M |
|
$3.11M |
|
$3.11M |
|
$3.11M |
|
193.00M |
|
| Cash Flow Statement Financials | |
$-105.04M |
|
$-0.88M |
|
$61.49M |
|
$95.29M |
|
$50.85M |
|
$-44.44M |
|
$9.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
0.95 |
|
20.86 |
|
-376.05% |
|
-5306.03% |
|
|
EBIT Margin |
-5306.03% |
-4945.63% |
|
-2003.58% |
|
-2003.58% |
|
$-105.93M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.71 |
|
4.62 |
|
78.98 |
|
-1313.38% |
|
-1313.38% |
|
-35.09% |
|
-62.31% |
|
$0.02 |
|
$-0.67 |
|
$-0.66 |
|